FACTORS INFLUENCING PLATELET SEROTONIN UPTAKE IN ESSENTIAL-HYPERTENSION

被引:10
作者
JAFRI, SM
CHANDRA, N
DHAWAN, S
SONI, D
CHANDRA, M
SHANKER, K
机构
[1] KING GEORGE V MEM HOSP,DEPT MED,LUCKNOW 226003,UTTAR PRADESH,INDIA
[2] KING GEORGE V MEM HOSP,DEPT PHARMACOL,LUCKNOW 226003,UTTAR PRADESH,INDIA
关键词
PLATELET; SEROTONIN; ESSENTIAL HYPERTENSION;
D O I
10.1016/0167-5273(92)90031-W
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In a study of the mechanism(s) of platelet serotonin uptake alteration in essential hypertension, a total of 90 blood samples were analysed for platelet count and platelet serotonin uptake. These included 20 blood samples each of hypertensives, controls before and after cross-incubation experiments and 10 samples of hypertensives after control of blood pressure. It was observed that, serotonin uptake was markedly reduced in hypertensive platelets. Diminished serotonin uptake in essential hypertension correlated directly with diastolic and mean arterial blood pressure and inversely with plasma total cholesterol values. In cross-incubation experiments using control platelets and hypertensive plasma, there was a significant reduction in platelet serotonin uptake (303.06 +/- 86.28 cpm/10(8) vs. 204.26 +/- 66.45 cpm/10(8); P < 0.001), whereas hypertensive platelets when incubated with control plasma, showed increased serotonin uptake (233.50 +/- 75.19 cpm/10(8) vs. 312.64 +/- 79.54 cpm/10(8); P < 0.01). Upon control of blood pressure, the platelet serotonin uptake improved significantly (205.45 +/- 70.0 cpm/10(8) vs. 266.77 +/- 61.68 cpm/10(8); P < 0.05-0.01). From these results, it appears that reduced platelet serotonin uptake in essential hypertension is a reversible phenomenon probably governed by the presence of plasma factor(s) and/or altered platelet-membrane function.
引用
收藏
页码:327 / 333
页数:7
相关论文
共 26 条
[1]   5-HYDROXYTRYPTAMINE IN BLOOD-PLATELETS OF CIRRHOTIC AND HYPERTENSIVE PATIENTS [J].
AHTEE, L ;
PENTIKAINEN, L ;
PENTIKAINEN, PJ ;
PAASONEN, MK .
EXPERIENTIA, 1974, 30 (11) :1328-1329
[2]   UPTAKE OF SEROTONIN BY HUMAN-PLATELETS AND ITS RELEVANCE TO CNS INVOLVEMENT IN HYPERTENSION [J].
BHARGAVA, KP ;
RAINA, N ;
MISRA, N ;
SHANKER, K ;
VRAT, S .
LIFE SCIENCES, 1979, 25 (02) :195-199
[3]  
BIONDI ML, 1986, J HYPERTENSION S, V4, P539
[4]   STUDIES ON THE UPTAKE OF 5-HYDROXYTRYPTAMINE BY BLOOD PLATELETS [J].
BORN, GVR ;
GILLSON, RE .
JOURNAL OF PHYSIOLOGY-LONDON, 1959, 146 (03) :472-491
[5]  
CHANDRA M, 1990, INDIAN J EXP BIOL, V28, P96
[6]  
CLOIX JF, 1987, KLIN WOCHENSCHR, V65, P146
[7]   PURIFICATION FROM HUMAN-PLASMA OF ENDOGENOUS SODIUM-TRANSPORT INHIBITOR(S) [J].
CLOIX, JF ;
DAGHER, G ;
CRABOS, M ;
PERNOLLET, MG ;
MEYER, P .
EXPERIENTIA, 1984, 40 (12) :1380-1382
[8]   TRYPTOPHAN-INDUCED LOWERING OF BLOOD-PRESSURE AND CHANGES OF SEROTONIN UPTAKE BY PLATELETS IN PATIENTS WITH ESSENTIAL-HYPERTENSION [J].
FELTKAMP, H ;
MEURER, KA ;
GODEHARDT, E .
KLINISCHE WOCHENSCHRIFT, 1984, 62 (23) :1115-1119
[9]   HYDROXY-TRYPTAMINE AND DOPAMINE TRANSPORT BY RAT AND HUMAN-BLOOD PLATELETS [J].
GORDON, JL ;
OLVERMAN, HJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1978, 62 (02) :219-226
[10]  
GROSS F, 1984, MANAGEMENT ARTERIAL